Peptide leads new class of chronic pain drugs

Nat Biotechnol. 2005 Apr;23(4):399. doi: 10.1038/nbt0405-399.
No abstract available

Publication types

  • News

MeSH terms

  • Calcium Channel Blockers / therapeutic use*
  • Calcium Channels, N-Type / drug effects*
  • Chronic Disease
  • Humans
  • NAV1.8 Voltage-Gated Sodium Channel
  • Neurons, Afferent / drug effects
  • Pain / drug therapy*
  • Peptides / therapeutic use*
  • Pregabalin
  • Sodium Channels / therapeutic use
  • gamma-Aminobutyric Acid / analogs & derivatives*
  • gamma-Aminobutyric Acid / therapeutic use
  • omega-Conotoxins / therapeutic use

Substances

  • Calcium Channel Blockers
  • Calcium Channels, N-Type
  • NAV1.8 Voltage-Gated Sodium Channel
  • Peptides
  • SCN10A protein, human
  • Sodium Channels
  • omega-Conotoxins
  • Pregabalin
  • gamma-Aminobutyric Acid
  • ziconotide